Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Financing, Personal | 4 | 2005 | 21 | 0.830 |
Why?
|
| Drug Prescriptions | 3 | 2017 | 141 | 0.720 |
Why?
|
| Prescription Fees | 3 | 2011 | 10 | 0.610 |
Why?
|
| Patients | 2 | 2008 | 100 | 0.590 |
Why?
|
| Methadone | 1 | 2017 | 36 | 0.590 |
Why?
|
| Drug Overdose | 1 | 2017 | 65 | 0.560 |
Why?
|
| Pain | 1 | 2017 | 391 | 0.490 |
Why?
|
| Medicaid | 1 | 2017 | 217 | 0.490 |
Why?
|
| Drug Approval | 2 | 2011 | 62 | 0.480 |
Why?
|
| Primary Health Care | 2 | 2008 | 339 | 0.480 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2011 | 17 | 0.410 |
Why?
|
| Amines | 1 | 2011 | 27 | 0.410 |
Why?
|
| Health Care Surveys | 3 | 2011 | 278 | 0.400 |
Why?
|
| Prescription Drugs | 1 | 2011 | 36 | 0.390 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 83 | 0.390 |
Why?
|
| Conflict of Interest | 1 | 2011 | 67 | 0.390 |
Why?
|
| Off-Label Use | 1 | 2011 | 16 | 0.390 |
Why?
|
| Anticonvulsants | 1 | 2011 | 126 | 0.370 |
Why?
|
| Drug Discovery | 1 | 2011 | 103 | 0.370 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 123 | 0.360 |
Why?
|
| Health Services Research | 1 | 2009 | 136 | 0.330 |
Why?
|
| Fees, Pharmaceutical | 1 | 2008 | 4 | 0.330 |
Why?
|
| Marketing | 1 | 2008 | 23 | 0.320 |
Why?
|
| Beneficence | 1 | 2008 | 33 | 0.320 |
Why?
|
| Truth Disclosure | 1 | 2008 | 87 | 0.300 |
Why?
|
| Personal Autonomy | 1 | 2008 | 112 | 0.300 |
Why?
|
| Physician's Role | 2 | 2006 | 179 | 0.300 |
Why?
|
| Attitude to Health | 2 | 2005 | 220 | 0.300 |
Why?
|
| Bioterrorism | 1 | 2006 | 18 | 0.280 |
Why?
|
| Health Priorities | 1 | 2006 | 23 | 0.280 |
Why?
|
| Fees, Medical | 1 | 2005 | 10 | 0.280 |
Why?
|
| Practice Management, Medical | 1 | 2005 | 24 | 0.270 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 1169 | 0.270 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 378 | 0.270 |
Why?
|
| Heartburn | 1 | 2005 | 9 | 0.270 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2011 | 582 | 0.260 |
Why?
|
| Nonprescription Drugs | 1 | 2005 | 15 | 0.260 |
Why?
|
| United States | 7 | 2017 | 6672 | 0.260 |
Why?
|
| Communication | 2 | 2008 | 441 | 0.260 |
Why?
|
| Public Health | 1 | 2006 | 129 | 0.250 |
Why?
|
| Communication Barriers | 1 | 2004 | 29 | 0.250 |
Why?
|
| Emergency Medicine | 1 | 2006 | 123 | 0.250 |
Why?
|
| Reimbursement Mechanisms | 2 | 2017 | 41 | 0.250 |
Why?
|
| Cost Control | 1 | 2004 | 44 | 0.250 |
Why?
|
| Resource Allocation | 1 | 2004 | 65 | 0.240 |
Why?
|
| Health Care Rationing | 1 | 2004 | 83 | 0.230 |
Why?
|
| Health Expenditures | 1 | 2004 | 86 | 0.230 |
Why?
|
| Physician-Patient Relations | 2 | 2005 | 610 | 0.220 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 806 | 0.190 |
Why?
|
| United States Food and Drug Administration | 2 | 2011 | 127 | 0.190 |
Why?
|
| Clinical Competence | 1 | 2006 | 751 | 0.190 |
Why?
|
| Office Visits | 2 | 2011 | 44 | 0.180 |
Why?
|
| Humans | 14 | 2017 | 86643 | 0.150 |
Why?
|
| Hypertension | 1 | 2005 | 1141 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2006 | 1621 | 0.140 |
Why?
|
| Middle Aged | 7 | 2011 | 25028 | 0.130 |
Why?
|
| Health Policy | 1 | 2017 | 180 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2017 | 814 | 0.120 |
Why?
|
| Patents as Topic | 1 | 2011 | 12 | 0.100 |
Why?
|
| Male | 7 | 2008 | 40965 | 0.100 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2011 | 37 | 0.100 |
Why?
|
| Organizational Objectives | 1 | 2011 | 27 | 0.100 |
Why?
|
| Drug Labeling | 1 | 2011 | 41 | 0.100 |
Why?
|
| Comparative Effectiveness Research | 1 | 2011 | 53 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2011 | 65 | 0.090 |
Why?
|
| Drug Costs | 1 | 2011 | 62 | 0.090 |
Why?
|
| Aged | 4 | 2011 | 18415 | 0.090 |
Why?
|
| Economics | 1 | 2009 | 11 | 0.090 |
Why?
|
| Clinical Medicine | 1 | 2009 | 34 | 0.090 |
Why?
|
| Equipment and Supplies | 1 | 2009 | 30 | 0.090 |
Why?
|
| Policy Making | 1 | 2009 | 62 | 0.090 |
Why?
|
| Biguanides | 1 | 2008 | 7 | 0.090 |
Why?
|
| Time Factors | 2 | 2011 | 5210 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 223 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 454 | 0.080 |
Why?
|
| Sulfonylurea Compounds | 1 | 2008 | 64 | 0.080 |
Why?
|
| Drug Therapy | 1 | 2008 | 70 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 82 | 0.080 |
Why?
|
| Female | 6 | 2008 | 44532 | 0.080 |
Why?
|
| Grief | 1 | 2008 | 4 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2008 | 224 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 429 | 0.080 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 92 | 0.080 |
Why?
|
| Nuclear Family | 1 | 2008 | 92 | 0.080 |
Why?
|
| Drug Industry | 1 | 2008 | 54 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2006 | 2501 | 0.080 |
Why?
|
| Adult | 4 | 2011 | 25648 | 0.080 |
Why?
|
| Death | 1 | 2008 | 73 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2008 | 117 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2008 | 160 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2008 | 227 | 0.070 |
Why?
|
| Diagnosis-Related Groups | 1 | 2005 | 20 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 228 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 567 | 0.070 |
Why?
|
| Adolescent | 2 | 2011 | 8981 | 0.070 |
Why?
|
| Consumer Behavior | 1 | 2005 | 29 | 0.070 |
Why?
|
| Midwestern United States | 1 | 2005 | 76 | 0.070 |
Why?
|
| Social Class | 1 | 2005 | 128 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 971 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 6509 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2005 | 169 | 0.060 |
Why?
|
| Cardiology | 1 | 2005 | 123 | 0.060 |
Why?
|
| Data Collection | 1 | 2005 | 372 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1036 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2005 | 203 | 0.060 |
Why?
|
| Insulin | 1 | 2008 | 1160 | 0.060 |
Why?
|
| Waiting Lists | 1 | 2004 | 175 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 999 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2005 | 347 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 636 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2004 | 508 | 0.040 |
Why?
|
| Child | 1 | 2011 | 6927 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 5976 | 0.040 |
Why?
|
| Risk Factors | 1 | 2005 | 5417 | 0.030 |
Why?
|